FTC Says PBMs’ Lawsuit Trying to Block In-House Case Lacks Merit

December 19, 2024, 4:51 PM UTC

The Federal Trade Commission has moved to axe a lawsuit claiming its case against three major US pharmacy benefit managers over rising insulin prices can’t proceed in its administrative court.

Units of CVS Health Corp., Cigna Group, and UnitedHealth Group Inc. in November sued the FTC claiming its in-house proceeding is unconstitutional and deprives them of due process rights they’d be entitled to in a trial court.

That attack is not “legally viable, much less capable of supporting their request for the extraordinary relief of a preliminary injunction,” the FTC said in a motion filed late Wednesday in ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.